Meet our people

Chris Loughlin, CEO, joined BrainCheck in October 2024. Since March 2020, he has served as Managing Partner at Pixiu Investments, a private equity firm in Austin, Texas, where he oversees investments in Austin F.C., Socialsuite, Tiff’s Treats, and Easy Tiger. From February 2016 to March 2020, he was CEO of Digital Pharmacist, a patient engagement platform for pharmacies, leading a significant scale-up from fewer than 200 pharmacies and less than $1M in ARR to 7,500 pharmacies, millions of patients, and over $20M in ARR. Digital Pharmacist was acquired by K1 Investment Management in December 2018.

From September 2001 to December 2015, he held various senior positions at Travelzoo (NASDAQ: TZOO), where he developed the company’s hotel, tour operator, and airline products and revenue streams, and launched and scaled its European business. Serving as CEO for 5 1/2 years, he led the company to $160M+ in revenue, meeting or beating the Street in 20 out of 22 quarters. During his tenure, Travelzoo grew to 600 employees, expanded to 26 offices worldwide, scaled to 30 million subscribers globally, and was recognized on Crain’s list of Best Places to Work.

Chris holds a BSc (Honors) in Technology Management from Staffordshire University, as well as an MBA from the University of California, Berkeley Haas School of Business focused on entrepreneurship and strategy, and an MBA from Columbia Business School focused on finance.

Chris is active in the Austin community; he is the former Board Chair of YPO Austin and the current Education Chair of YPO Austin Gold. He served on the National Leadership Board of the Blanton Museum of Art at the University of Texas. He was recognized as Young Entrepreneur of the Year by Barclays Commercial and “Most Likely to Challenge the Status Quo” by alumni of the University of California, Haas School of Business.

Chris has extensive public speaking experience, having appeared on Jim Cramer’s Mad Money twice, spoken at the Goldman Sachs and JP Morgan Internet Media Conferences, and served as a keynote speaker for 4,500+ pharmacists at the Cardinal Health Annual Convention in San Diego. Chris is married to Kathleen Irvin Loughlin, an Austin-based philanthropist focused on women in the arts and a Tony Award-winning producer. They have two children. Chris has a family history of dementia and Alzheimer’s and is motivated to develop digital products that can have a positive impact.

Dr. David Eagleman is a visionary leader in the neuroscience field. He currently teaches at Stanford University and heads the Center for Science and Law. In addition to receiving numerous awards for his academic research and work, David is a New York Times best-selling author, a TED speaker, and the creator and host of the Emmy-nominated PBS series, The Brain.

Dr. Reza Hosseini Ghomi is a practicing neuropsychiatrist, focused on neurodegenerative disorders. In addition to serving as Chief Medical Officer at BrainCheck, he is faculty of the University of Washington department of neurology and Institute for Neuroengineering. Reza received his MD from the University of Massachusetts Medical School, has post-graduate training in psychiatry and neurology, and holds an MSE in biomedical and electrical engineering from Johns Hopkins University.

Matt is an accomplished leader with 15 years of experience driving top line revenue for medical device and digital health solutions across the provider and payer landscape. His collaborative approach to transforming sales processes to align with a strategic vision has proven to dramatically fuel growth and business development initiatives.

Jennifer Cobb is an accomplished healthcare leader with more than 15 years of experience in risk adjustment, value-based care, and managing government programs. She comes to BrainCheck from Aetna, where she specialized in revenue optimization and medical loss ratio management. Prior to this role, she held senior executive positions at Signify Health, Priority Health, and the U.S. Department of Veterans Affairs. She holds a Bachelor of Science degree in Advertising and Electronic Media from Northern Arizona University and a Master of Public Administration from Arizona State University.

William “Billy” Sierra-Lenhart is a renowned engineer and artist whose career has traversed technology, art, defense, and communications. Billy has provided consulting support to clients ranging from political candidates to transportation service providers, and founded a number of start-ups including DisruptDev and ThaTrunk. After several years of driving the modernization of the Pearson Clinical digital assessment platform, Billy joined BrainCheck in 2018 as Director of Technology, steering the product as it pivoted to the clinical space. After being named Director of Engineering in 2019, Billy was named Vice-President of Engineering in 2021.

Tommy Pfeiffer has a decade of experience in early-stage healthcare technology companies, covering various areas including biometrics, population health analytics, bundled pricing/network development, post-acute analytics, and digital assessments. He applies his understanding of complex market dynamics paired with the ability to operate in a fast-paced environment to leading Finance & Operations at BrainCheck. Leveraging his analytical skills, strategic mindset, and adaptability, he is focused on optimizing operational efficiencies to manage costs and drive revenue. He holds a Bachelor of Arts degree in Finance and Entrepreneurship from Miami University.

Mary Patterson is a clinical and operational leader committed to building standard of care medical technology portfolios and advancing healthcare through clinical research. She brings to BrainCheck a decade of experience in the neuroscience research space with expert familiarity in Alzheimer’s Disease, Neurointerventional and Neurovascular research and technology. She is a proven team manager with experience leading large scale Phase I through Phase IV IDE and IND clinical trials from study design and development through 510K and CE Mark approval. She holds a Bachelor of Arts degree in Neuroscience from Ohio University and a Masters of Science in Aging and Neuroscience from the University of South Florida